| Name | Title | Contact Details |
|---|
Search and apply for federal jobs. Learn about unique hiring paths for veterans, students and graduates, individuals with a disability, and more.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Connect any system. Automate your work. Coefficient automatically syncs Google Sheets with your business systems.
Coaxis partners with employers of all types and sizes; Banks, CPA Firms, Law Firms, Health Care, Governmental Consultants, Engineering Firms, Insurance Agencies, Association Management, Chamber of Commerce and numerous others who want to increase prod...
V5 Systems. Ongoing Intelligence. Anywhere. Developer of World’s first Self-Powered Outdoor Security and Computing Platform for the Industrial IoT